ProHealth health Vitamin and Natural Supplement Store and Health
Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help

|
|
|
|

Trending News

Missing protein explains link between obesity, diabetes

Fish oil use associated with brain volume preservation

The Brain Boosting and Fatigue Fighting B-12

Genetic basis for distinct type of autism uncovered

Unsuspected aspect of immune regulation revealed: Role of B cells

IBS, Crohn’s Disease, Colitis, and Other Digestive Disorders

Explaining 'Healthy' Obesity

Sinus Congestion and Sinusitis, Healing Naturally

Omega 3 Fatty Acids Lessen Severity of Osteoarthritis in Mice

In the gut, immunity is a two-way street

 
Print Page
Email Article

Canadian Recommendations for Rational Care of Persons with Fibromyalgia

  [ Not Yet Rated ]   [ Discuss This Article ]
www.ProHealth.com • July 11, 2013


Editor's comment:  This report, issued by the Canadian Pain Society and Canadian Rheumatology Association, appears to be a summary of the "New Canadian Guidelines for Treating Fibromyalgia" released in May 2013. 

Canadian Pain Society and Canadian Rheumatology Association Recommendations for Rational Care of Persons with Fibromyalgia. A Summary Report.

By Mary-Ann Fitzcharles, et al.

Abstract:

OBJECTIVE: To summarize the development of evidence-based guidelines for the clinical care of persons with fibromyalgia (FM), taking into account advances in understanding of the pathogenesis of FM, new diagnostic criteria, and new treatment options.

METHODS: Recommendations for diagnosis, treatment, and patient followup were drafted according to the classification system of the Oxford Centre for Evidence-Based Medicine, and following review were endorsed by the Canadian Rheumatology Association and the Canadian Pain Society.

RESULTS:

  • FM is a polysymptomatic syndrome presenting a spectrum of severity, with a pivotal symptom of body pain.

  • FM is a positive clinical diagnosis, not a diagnosis of exclusion, and not requiring specialist confirmation.

  • There are no confirmatory laboratory tests, although some investigation may be indicated to exclude other conditions.

  • Ideal care is in the primary care setting, incorporating nonpharmacologic and pharmacologic strategies in a multimodal approach with active patient participation.

  • The treatment objective should be reduction of symptoms, but also improved function using a patient-tailored treatment approach that is symptom-based.

  • Self-management strategies combining good lifestyle habits and fostering a strong locus of control are imperative.

  • Medications afford only modest relief, with doses often lower than suggested, and drug combinations used according to clinical judgment.

  • There is a need for continued reassessment of the risk-benefit ratio for any drug treatment.

  • Outcome should be aimed toward functioning within a normal life pattern and any culture of disablement should be discouraged.

CONCLUSION: These guidelines should provide the health community with reassurance for the global care of patients with FM with the aim of improving patient outcome by reducing symptoms and maintaining function.

Source: Journal of Rheumatology, July 1, 2013. By Mary-Ann Fitzcharles, Peter A. Ste-Marie, Don L. Goldenberg, John X. Pereira, Susan Abbey, Manon Choinière, Gordon Ko, Dwight E. Moulin, Pantelis Panopalis, Johanne Proulx and Yoram Shir.  From the Division of Rheumatology, McGill University, Montreal, Quebec; Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, Quebec; Faculty of Law, Université de Montréal, Montreal, Quebec, Canada; Division of Rheumatology, Tufts University School of Medicine, Boston, Massachusetts, USA; Faculty of Medicine, University of Calgary, Calgary, Alberta; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario; Centre de la recherche du Centre hospitalier de l'Université de Montréal, and Department of Anesthesiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec; Division of Physiatry, University of Toronto, Toronto, Ontario; and departments of Clinical Neurological Sciences and Oncology, University of Western Ontario, London, Ontario, Canada.





Discuss This Article Post a Comment 




[ Be the first to comment on this article ]




 
Free Chronic Fatigue Syndrome and Fibromyalgia Newsletters
Subscribe to
Our FREE
Newsletter
Subscribe Now!
Receive up-to-date ME/CFS & Fibromyalgia treatment and research news
 Privacy Guaranteed  |  View Archives

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ by ProHealth Vitamin D3 Extreme™ by ProHealth
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ by ProHealth FibroSleep™ by ProHealth
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® by ProHealth Optimized Curcumin Longvida® by ProHealth
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

The Brain Boosting and Fatigue Fighting B-12 The Brain Boosting and Fatigue Fighting B-12
Broad Spectrum Protection Against Brain Aging Broad Spectrum Protection Against Brain Aging
2 test library cats 2 test library cats
Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue Magnesium + Malic Acid: One-Two Punch for Pain & Fatigue
Dreaming of a Good Night's Sleep? Dreaming of a Good Night's Sleep?

FIBROMYALGIA RESOURCES
What is Fibromyalgia?
Fibromyalgia 101
Fibromyalgia Symptoms
Fibromyalgia Treatments
| CFS RESOURCES
What is CFS?
ME/CFS 101
ME/CFS Symptoms
ME/CFS Treatments
| FORUMS
Fibromyalgia
ME/CFS
ADVANCED MEDICAL LABS
WHOLESALE  |  AFFILIATES
GUARANTEE
CONTACT US
PRIVACY
RSS
SITE MAP
ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus
Credit Card Processing